Studying the Impact of a Medication Use Evaluation by the Community Pharmacist
NCT ID: NCT03179722
Last Updated: 2019-07-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
453 participants
INTERVENTIONAL
2016-11-08
2018-10-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Exploratory Study to Inventory Opportunities to Optimize Continuity of Pharmacotherapy at Hospital Discharge
NCT03223584
Polymedication Check - a Randomised Controlled Trial
NCT01739816
Implementation of a Pharmacy-Intervention to Enhance Prescription and Use of Lipid-Lowering Drugs
NCT00509717
Benefit of a Collaborative Approach to Improve the Quality of Medicines Use in Elderly Inpatients
NCT00279656
Community Pharmacist Intervention to Enhance Adherence in Cardiovascular Drug Initiators
NCT06142838
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention group: Frenchspeaking patients
Intervention: Medication review
Medication review
The intervention consists of a medicines use review provided by community pharmacists in Belgium. A medicines use review is a medication review type 2a in which both a patient interview and dispensing data are used as information sources to identify drug-related problems with a specific focus on the medicines use of the patient.
Intervention group: Dutchspeaking patients
Intervention: Medication review Intervention: Dutchspeaking patients are also invited to participate to Additional data collection: questionnaires
Medication review
The intervention consists of a medicines use review provided by community pharmacists in Belgium. A medicines use review is a medication review type 2a in which both a patient interview and dispensing data are used as information sources to identify drug-related problems with a specific focus on the medicines use of the patient.
Additional data collection: questionnaires
Pre-post study design.
At three timepoints, data is collected:
* before the medication review (T-1week)
* during the review (Tweek 3)
* after the review (Tweek12) The questionnaire provide data for the outcomes: medication related quality of life, adherence questionnaire, service satisfaction, use of emergency health services, self-management
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Medication review
The intervention consists of a medicines use review provided by community pharmacists in Belgium. A medicines use review is a medication review type 2a in which both a patient interview and dispensing data are used as information sources to identify drug-related problems with a specific focus on the medicines use of the patient.
Additional data collection: questionnaires
Pre-post study design.
At three timepoints, data is collected:
* before the medication review (T-1week)
* during the review (Tweek 3)
* after the review (Tweek12) The questionnaire provide data for the outcomes: medication related quality of life, adherence questionnaire, service satisfaction, use of emergency health services, self-management
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Use five or more drugs on a regular basis (prescription or non-prescription drugs)
* Live in the ambulatory setting
* Obtain his medication from this pharmacy on a regular basis
Exclusion Criteria
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Association of Belgian Pharmacies (APB)
UNKNOWN
Joke Wuyts
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Joke Wuyts
PharmD
References
Explore related publications, articles, or registry entries linked to this study.
Wuyts J, Maesschalck J, De Wulf I, Foubert K, Boussery K, De Lepeleire J, Foulon V. Studying the impact of a medication use evaluation for polymedicated older patients by the community pharmacist (SIMENON): study protocol. BMC Health Serv Res. 2018 Aug 8;18(1):623. doi: 10.1186/s12913-018-3440-z.
Related Links
Access external resources that provide additional context or updates about the study.
Protocol Abstract for the PCNE conference 2017 (DOI: 10.1007/s11096-017-0462-2)
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SIMENONv3
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.